Concepedia
4
Publications
362
Citations
H-Index
2012
Active since
Affiliations
Emory University(Current)
Janssen (Belgium)
Harvard University
Millennium Engineering and Integration (United States)
Janssen (United States)
David I. Lichter is an author at Emory University.
Publications per year
2012–2020
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy
George Mulligan, David I. Lichter, Alessandra Di Bacco et al. · Blood · 2013 · 115 citations · Full text
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis
Matthew R. Henn, Edward J. O’Brien, Liyang Diao et al. · Gastroenterology · 2020 · 102 citations · Full text
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines
Erika von Euw, Mohammad Atefi, Narsis Attar et al. · Molecular Cancer · 2012 · 74 citations · Full text
Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone
David I. Lichter, Hadi Danaee, Michael D. Pickard et al. · Blood · 2012 · 71 citations · Full text
Rows per page
1–4 of 4